Futura Financial Statements From 2010 to 2025
| FAMDF Stock | USD 0.01 0.02 66.67% |
Check Futura Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Futura Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Futura financial statements analysis is a perfect complement when working with Futura Medical Valuation or Volatility modules.
Futura |
Futura Medical plc Company Current Valuation Analysis
Futura Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Futura Medical Current Valuation | 157.14 M |
Most of Futura Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Futura Medical plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Futura Medical plc has a Current Valuation of 157.14 M. This is 98.91% lower than that of the Healthcare sector and 96.62% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.05% higher than that of the company.
Futura Medical plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Futura Medical's current stock value. Our valuation model uses many indicators to compare Futura Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Futura Medical competition to find correlations between indicators driving Futura Medical's intrinsic value. More Info.Futura Medical plc is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Futura Medical's earnings, one of the primary drivers of an investment's value.About Futura Medical Financial Statements
Futura Medical stakeholders use historical fundamental indicators, such as Futura Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Futura Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Futura Medical's assets and liabilities are reflected in the revenues and expenses on Futura Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Futura Medical plc. Please read more on our technical analysis and fundamental analysis pages.
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom. Futura Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Futura Pink Sheet
Futura Medical financial ratios help investors to determine whether Futura Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Futura with respect to the benefits of owning Futura Medical security.